Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study

被引:23
作者
Niguma, T [1 ]
Mimura, T [1 ]
Tutui, N [1 ]
机构
[1] Okayama Saiseikai Gen Hosp, Dept Surg, Okayama 7008511, Japan
来源
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY | 2005年 / 12卷 / 03期
关键词
tumor thrombosis; adjuvant arterial infusion chemotherapy; hepatic arterial infusion chemotherapy; hepatocellular carcinoma;
D O I
10.1007/s00534-004-0969-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Purpose. The prognosis of hepatocellular carcinoma (HCC) with tumor thrombosis of the main trunk or major branches of the portal vein (mPVTT) is extremely poor, even if it is curatively resected. Uncontrollable multiple metastases to the residual liver are often observed within several months after the operation. We report here the results of a pilot study, showing the efficacy of adjuvant arterial infusion chemotherapy after the resection of HCC with mPVTT. Methods. Twelve patients had curative resection of HCC with mPVTT. Six of the patients were treated by the arterial infusion of a chemotherapeutic agent via a subcutaneously implanted injection port after curative resection of HCC with mPVTT. The initial course consisted of the daily administration of cisplatin (CDDP) and continuous infusion of 5-fluorouracil (5-FU). This was followed by the weekly or biweekly administration of CDDP and subsequent infusion of 5-FU until the cumulative dose of 5-FU reached 15 g. Results. The median overall survival time was 58.0 months with adjuvant chemotherapy and 8.0 months without adjuvant chemotherapy. The median disease-free interval was 15.0 months with adjuvant chemotherapy and 4.0 months without adjuvant chemotherapy. Adverse reactions were tolerable nausea and loss of appetite. Conclusions. This chemotherapeutic regimen achieved favorable results and may be useful as adjuvant chemotherapy in treating patients after curative resection of HCC with mPVTT.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 41 条
  • [11] ISHII K, 1992, AM J GASTROENTEROL, V87, P118
  • [12] Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein
    Itamoto, T
    Nakahara, H
    Tashiro, H
    Haruta, N
    Asahara, T
    Naito, A
    Ito, K
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (03) : 143 - 148
  • [13] Kamiyama Hidenori, 2002, J Hepatobiliary Pancreat Surg, V9, P759, DOI 10.1007/s005340200106
  • [14] KUMADA K, 1990, SURGERY, V108, P821
  • [15] Lee HS, 1997, CANCER-AM CANCER SOC, V79, P2087, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.3.CO
  • [16] 2-4
  • [17] Natural history of untreated nonsurgical hepatocellular carcinoma:: Rationale for the design and evaluation of therapeutic trials
    Llovet, JM
    Bustamante, J
    Castells, A
    Vilana, R
    Ayuso, MD
    Sala, M
    Brú, C
    Rodés, J
    Bruix, J
    [J]. HEPATOLOGY, 1999, 29 (01) : 62 - 67
  • [18] Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    Mazzaferro, V
    Regalia, E
    Doci, R
    Andreola, S
    Pulvirenti, A
    Bozzetti, F
    Montalto, F
    Ammatuna, M
    Morabito, A
    Gennari, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 693 - 699
  • [19] LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA
    MCPEAKE, J
    WILLIAMS, R
    [J]. GUT, 1995, 36 (05) : 644 - 646
  • [20] TRANSCATHETER OILY CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA
    NAKAMURA, H
    HASHIMOTO, T
    OI, H
    SAWADA, S
    [J]. RADIOLOGY, 1989, 170 (03) : 783 - 786